Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957
Junfeng Liu, David J Stevens, Lesley F Haire, et al.
The Journal of Head Trauma Rehabilitation
|
June 19, 2021
Should We Lose Sleep Over Sleep Disturbances After Sports-Related Concussion? A Scoping Review of the Literature
David J Stevens, Alia Alghwiri, Sarah L Appleton, et al.
Nature
|
August 18, 2006
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J Russell, Lesley F Haire, David J Stevens, et al.
The European Respiratory Journal
|
July 7, 2018
Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Sophie G Carter, Jayne C Carberry, Garry Cho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 26, 2004
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins
Ola Blixt, Steve Head, Tony Mondala, et al.
Nature
|
November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors
Shinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.
Virology
|
September 21, 2013
Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding
Martin Crusat, Junfeng Liu, Angelina S Palma, et al.
The Lancet. Rheumatology
|
March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial
Jon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
Annals of the Rheumatic Diseases
|
July 9, 2023
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Mikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957
Junfeng Liu, David J Stevens, Lesley F Haire, et al.
The Journal of Head Trauma Rehabilitation
|
June 19, 2021
Should We Lose Sleep Over Sleep Disturbances After Sports-Related Concussion? A Scoping Review of the Literature
David J Stevens, Alia Alghwiri, Sarah L Appleton, et al.
Nature
|
August 18, 2006
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J Russell, Lesley F Haire, David J Stevens, et al.
The European Respiratory Journal
|
July 7, 2018
Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Sophie G Carter, Jayne C Carberry, Garry Cho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 26, 2004
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins
Ola Blixt, Steve Head, Tony Mondala, et al.
Nature
|
November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors
Shinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.
Virology
|
September 21, 2013
Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding
Martin Crusat, Junfeng Liu, Angelina S Palma, et al.
The Lancet. Rheumatology
|
March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial
Jon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
Annals of the Rheumatic Diseases
|
July 9, 2023
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Mikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin, et al.
Page
of 2